weight loss medication retatrutide Who Makes Retatrutide? Company Behind the Drug VisualAbstract: Retatrutide reduces body weight

Retatrutide targets GLP-1, GIP, and glucagon receptors simultaneously, making it a potentially significant advance in the management of obesity and type 2 diabetes

Those in the 35 to 40 BMI range averaged 24.1%, while participants above BMI 40 saw 21.3% reduction

However, it is worth considering that routes of administration cannot be easily compared as dose frequency and specific details of the treatment process administration can impact patient preference

GLP-1 helps regulate blood sugar levels by stimulating the release of insulin, suppressing glucagon secretion (which raises blood sugar levels), and slowing the rate at which the stomach empties, leading to a feeling of fullness and reduced appetite